Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis
2019-000406-30Phase 3Terminated
- Sponsor
- Allergan
- Start
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of relamorelin in diabetic gastroparesis, sponsored by Allergan. Started Jun 2020; status: terminated.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on 2019-000406-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000406-30.